These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32355642)

  • 1. Prognostic importance of lymph node yield after curative resection of gastroenteropancreatic neuroendocrine tumours.
    Chiramel J; Almond R; Slagter A; Khan A; Wang X; Lim KHJ; Frizziero M; Chakrabarty B; Minicozzi A; Lamarca A; Mansoor W; Hubner RA; Valle JW; McNamara MG
    World J Clin Oncol; 2020 Apr; 11(4):205-216. PubMed ID: 32355642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence-free survival.
    Daskalakis K; Wedin M; Tsoli M; Kogut A; Srirajaskanthan R; Sarras K; Kattiparambil S; Giovos G; Weickert MO; Kos-Kudla B; Kaltsas G
    J Neuroendocrinol; 2022 Nov; 34(11):e13205. PubMed ID: 36385444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
    Broadbent R; Wheatley R; Stajer S; Jacobs T; Lamarca A; Hubner RA; Valle JW; Amir E; McNamara MG
    Cancer Treat Rev; 2021 Dec; 101():102299. PubMed ID: 34662810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
    Lopez-Aguiar AG; Zaidi MY; Beal EW; Dillhoff M; Cannon JGD; Poultsides GA; Kanji ZS; Rocha FG; Marincola Smith P; Idrees K; Beems M; Cho CS; Fisher AV; Weber SM; Krasnick BA; Fields RC; Cardona K; Maithel SK
    Ann Surg Oncol; 2019 Aug; 26(8):2517-2524. PubMed ID: 31004295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?
    DePalo DK; Lee RM; Lopez-Aguiar AG; Gamboa AC; Rocha F; Poultsides G; Dillhoff M; Fields RC; Idrees K; Nathan H; Abbott D; Maithel SK; Russell MC;
    J Surg Oncol; 2019 Nov; 120(6):919-925. PubMed ID: 31385621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery.
    Slagter AE; Ryder D; Chakrabarty B; Lamarca A; Hubner RA; Mansoor W; O'Reilly DA; Fulford PE; Klümpen HJ; Valle JW; McNamara MG
    Surg Oncol; 2016 Sep; 25(3):223-8. PubMed ID: 27566026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis.
    Giuliante F; Ardito F; Guglielmi A; Aldrighetti L; Ferrero A; Calise F; Giulini SM; Jovine E; Breccia C; De Rose AM; Pinna AD; Nuzzo G
    JAMA Surg; 2016 Oct; 151(10):916-922. PubMed ID: 27556741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties.
    Kankava K; Maisonneuve P; Mangogna A; Centonze G; Cattaneo L; Prinzi N; Pusceddu S; Fazio N; Pisa E; Di Domenico S; Bertani E; Mazzaferro V; Albertelli M; Grillo F; Milione M
    J Neuroendocrinol; 2021 Aug; 33(8):e13000. PubMed ID: 34268808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of radiologically enlarged lymph nodes in node-negative colon cancer.
    Song W; Chen Z; Zheng Z; Hu J; Chen Y; Deng W; He X; Lan P
    Colorectal Dis; 2020 May; 22(5):537-543. PubMed ID: 31868954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
    Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
    Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node density predicts recurrence and death after inguinal lymph node dissection for penile cancer.
    Ball MW; Schwen ZR; Ko JS; Meyer A; Netto GJ; Burnett AL; Bivalacqua TJ
    Investig Clin Urol; 2017 Jan; 58(1):20-26. PubMed ID: 28097264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
    Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors.
    Martin JA; Warner RRP; Aronson A; Wisnivesky JP; Kim MK
    Pancreas; 2017 Oct; 46(9):1214-1218. PubMed ID: 28902794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The re-evaluation of optimal lymph node yield in stage II right-sided colon cancer: is a minimum of 12 lymph nodes adequate?
    Cai Y; Cheng G; Lu X; Ju H; Zhu X
    Int J Colorectal Dis; 2020 Apr; 35(4):623-631. PubMed ID: 31996986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors.
    Landry CS; Lin HY; Phan A; Charnsangavej C; Abdalla EK; Aloia T; Nicolas Vauthey J; Katz MH; Yao JC; Fleming JB
    World J Surg; 2013 Jul; 37(7):1695-700. PubMed ID: 23657749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between factor of parotid lymph node and prognosis in parotid cancer.
    Fang Q; Zhang X; Dai L; Luo R; Yuan J
    Eur J Surg Oncol; 2023 Aug; 49(8):1405-1410. PubMed ID: 37061402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative anemia: impact on short- and long-term outcomes following curative-intent resection of gastroenteropancreatic neuroendocrine tumors.
    Xiang JX; Nan YL; He J; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Maithel SK; Lv Y; Zhang XF; Pawlik TM
    J Gastrointest Surg; 2024 Jun; 28(6):852-859. PubMed ID: 38538480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.
    Sahara K; Tsilimigras DI; Mehta R; Moro A; Paredes AZ; Lopez-Aguiar AG; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho C; Beems M; Dillhoff M; Maithel SK; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Apr; 27(4):1203-1212. PubMed ID: 31838609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node size is not a reliable criterion for predicting nodal metastasis in rectal neuroendocrine tumours.
    Kim BC; Kim YE; Chang HJ; Lee SH; Youk EG; Lee DS; Lee JB; Lee EJ; Kim MJ; Sohn DK; Oh JH
    Colorectal Dis; 2016 Jul; 18(7):O243-51. PubMed ID: 27166857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validated Risk-Score Model Predicting Lymph Node Metastases in Patients with Non-Functional Gastroenteropancreatic Neuroendocrine Tumors.
    Shannon AB; Straker RJ; Fraker DL; Miura JT; Karakousis GC
    J Am Coll Surg; 2022 May; 234(5):900-909. PubMed ID: 35426404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.